Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Oregon Health and Science University · with National Eye Institute (NEI) · NCT07065747
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 5–85 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 125
- US sites recruiting
- 1
- Study start
- September 1, 2024
- Record last updated
- July 17, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. Anterior uveitis is a type of inflammation in the eye that can be caused by many different diseases of the body.
Conditions: Anterior Uveitis (AU); Birdshot Chorioretinitis; Behcet Disease; Herpes Simplex Virus; Juvenile Idiopathic Arthritis (JIA); Spondyloarthritis (SA); Sarcoidosis; Posterior Vitreous Detachment
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Uveitis Group: Eyes with active intraocular inflammation and a clinical diagnose of spondyloarthritis/HLA-B27 associated anterior uveitis, Juvenile Idiopathic Arthritis (JIA) associated chronic anterior uveitis, Herpes Simplex Virus (HSV) anterior uveitis, Birdshot chorioretinitis, Behcet disease uveitis, sarcoidosis associated uveitis, uveitis of any additional type, or uveitis masquerade.
- Posterior Vitreous Detachment Group: Eyes with vitreous floaters and posterior vitreous detachment (PVD).
- Healthy/Control Group: Healthy eyes with no history of uveitis, PVD, or previous eye surgery.
Exclusion Criteria
- Inability to give informed consent.
- Inability to maintain stable fixation for OCT imaging.
- Inability to commit to required visits to complete the study.
- Pregnancy and breastfeeding.
Recruiting US locations
Casey Eye Institute - Oregon Health & Science University
Portland, OR 97239
Study contacts (from the official record)
- Humberto Martinez, COT, MBA · 503-494-7712 · martinhu@ohsu.edu
- Denzil Romfh, OD · 503-494-4351 · romfhd@ohsu.edu
Similar studies in Oregon
All arthritis studies in Oregon →- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Portland, OR + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 1
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Novartis Pharmaceuticals
- Location
- Portland, OR + 10 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee
Fin-Ceramica Faenza Spa
- Location
- Portland, OR + 7 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 2
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
Novartis Pharmaceuticals
- Location
- Portland, OR + 1 other US site
- Eligibility basics
- Ages 1+